Seeing Is Believing
Currently out of the existing stock ratings of Julian Harrison, 34 are a BUY (89.47%), 4 are a HOLD (10.53%).
Analyst Julian Harrison, currently employed at BTIG, carries an average stock price target met ratio of 51.52% that have a potential upside of 80.33% achieved within 324 days.
Julian Harrison’s has documented 71 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LQDA, Liquidia Technologies at 20-Aug-2024.
Analyst best performing recommendations are on AVTE (AEROVATE THERAPEUTICS).
The best stock recommendation documented was for AVTE (AEROVATE THERAPEUTICS) at 12/6/2022. The price target of $27 was fulfilled within 6 days with a profit of $8.97 (49.75%) receiving and performance score of 82.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$50
$8.89 (21.62%)
$50
6 days ago
(11-Nov-2024)
17/22 (77.27%)
$2.73 (5.78%)
264
Buy
$43
$1.89 (4.60%)
$45
3 months 10 days ago
(07-Aug-2024)
9/9 (100%)
$7.21 (20.15%)
185
Buy
$48
$6.89 (16.76%)
$37
3 months 23 days ago
(25-Jul-2024)
3/3 (100%)
$6.43 (15.47%)
163
Buy
$51
$9.89 (24.06%)
$41
3 months 24 days ago
(24-Jul-2024)
2/4 (50%)
$9.11 (21.75%)
629
Buy
$35
$-6.11 (-14.86%)
$35
1 years 4 months 14 days ago
(03-Jul-2023)
3/10 (30%)
$12.69 (56.88%)
557
Which stock is Julian Harrison is most bullish on?
Which stock is Julian Harrison is most reserved on?
What Year was the first public recommendation made by Julian Harrison?